• 3 hours U.S. Moves To Bar Iranians From Investor Visas
  • 1 day Why Germany Is Going To War With Gold
  • 2 days Gold Is Still Cheap Compared To Stocks
  • 3 days Are Cryptocurrencies Funding Terrorism?
  • 3 days Promising Oil Companies To Watch In 2020
  • 4 days Could China's Coronavirus Outbreak Impact U.S. Stocks?
  • 4 days Tesla Stock Continues To Soar
  • 5 days What New Economic Data Reveals About Gold's Trajectory
  • 6 days The Lucrative New Tech Hijacking Your Privacy
  • 6 days The Biggest Loser In The China-U.S. Tariff Tit-For-Tat
  • 7 days Trade War Takes Its Toll On Shipping
  • 9 days Is $90 Oil Possible? An Interview With Jay Park
  • 10 days Billions Of Dollars Are Flooding Into The Flying Taxi Space
  • 10 days Is This The Most Important Energy Project Of 2020?
  • 11 days Startups Are Dying To Give You A Better Death
  • 11 days U.S. Restaurants Are Struggling With Rising Labor Costs
  • 12 days The Banking Bonanza Is Just Getting Started
  • 12 days How The Trade War Ceasefire Will Impact The Energy Industry
  • 13 days Who Is The Most Dangerous Person On The Internet?
  • 13 days SoftBank Sees First Quarterly Loss In 14 Years
Tesla Stock Continues To Soar

Tesla Stock Continues To Soar

Since the beginning of January,…

Promising Oil Companies To Watch In 2020

Promising Oil Companies To Watch In 2020

It’s no secret that energy…

Could China's Coronavirus Outbreak Impact U.S. Stocks?

Could China's Coronavirus Outbreak Impact U.S. Stocks?

Millions of Chinese are expected…

  1. Home
  2. Investing
  3. Stocks

Cannabis Stock Valuations Are Spiraling Out Of Control

Marijuana

In trading circles they say that you should be scared when even diehard bears and ultra short-sellers start backing a stock. For instance, traders like Michael Lewis, author of The Big Short: Inside the Doomsday Machine, who has openly backed marijuana, terming it the big long …

But maybe that admonition does not apply to pot stocks, which have lately been on a serious tear that reminds you of bitcoin’s heyday.

Marijuana stocks are on a rampage following a report that Johnnie Walker and Smirnoff maker Diageo PLC is in talks with no less than three Canadian pot companies seeking to purchase a stake or partner with them. That continues the ongoing trend of large international companies striking mega deals with cannabis companies.

The Global Cannabis Stock Index has climbed seven percent since the news, and is nearly 30 percent above its August 14 low.

Pot stocks that have seen serious gains include Cronos Group (NASDAQ:CRON), Tilray Inc.(NASDAQ:TLRY) and Canopy Growth (NYSE:CGC), which have all gained more than 10 percent since Friday. Canadian pot stocks like Aurora Cannabis Inc.(OTCQX:ACBFF) have also staged string rallies.

Global Cannabis Stock Index

(Click to enlarge)

The Cannabis Holy Grail

The potential of a cannabis company striking a deal or entering into a partnership with a pharmaceutical company or beverage conglomerate is considered something of a Holy Grail by pot investors. The potential deal between Diageo and pot companies comes in the wake of a $4-billion investment by booze giant Constellation Brands Inc. (NYSE:STZ) into Canopy Growth. Related: Saudi King Overrules World’s Largest IPO

The Constellation-Canopy deal, the largest to-date, more or less opened the doors for other beverage manufacturers to pursue similar deals in a bid to stay ahead of competitors.

Legal recreational use of marijuana in Canada is set to go into effect in October. Though still largely illegal in its northern neighbor under U.S. federal law, a number of states including California, Washington and Colorado have already legalized the drug. Changing attitudes in favor of weed legalization have also been notable, withmultiple polls showing high public approval ratings of as much as 64 percent.

And that’s exactly what’s been giving beverage makers like Diageo sleepless nights.

Although there are no definitive timelines for legalization Stateside, marijuana could end up seriously hurting the booze industry. RBC Capital Markets has said that legal sales of marijuana in the U.S. are quickly catching up to beer and wine and could hit $47 billion in 10 years, implying a 17-percent CAGR.

Cowen and Company has predicted that the cannabis market will generate $75 billion annually by 2030 and significantly reduce binge drinking. Further, concentrates will take over the market, as is already happening in Colorado where sales of plain vanilla weed has dropped from 70 percent of sales to just 46 percent in the space of four years.

Related: Gold, Silver Up As Trade War Fears Take A Breather

The onus is therefore on beverage companies to figure a way to remain relevant as more states allow people to light up legally.

Adding cannabis-infused beverages to their portfolios is a strategy that’s gaining popularity, with Constellation Brands and Molson Coors Brewing (NYSE:TAP) having walked that road. Molson announced in August that it was forming a joint venture with The Hydropothecary Corp. to develop non-alcoholic cannabis-infused beverages aimed for the Canadian market.

Wall Street and bankers are beginning to warm up to these companies, with middle-market banks and hedge funds such as Tiger Brands and Canaccord Genuity now willing to play ball and finance these kinds of deals. Investors should, however, invest in pot stocks with caution due to their stratospheric valuations despite many having little in the way of actual revenues.

By Alex Kimani for Safehaven.com

More Top Reads From Safehaven.com

Back to homepage

Leave a comment

Leave a comment